To evaluate the effect of the combination of emodin and sorafenib on cholesterogenic gene expression, we analyzed HMGCS1, HMGCR, FDPS, DHCR7, and DHCR24 after treatment of HCC cells with emodin and sorafenib. This evidence concerns the gene HMGCR and hepatocellular carcinoma.